These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. Strom BL; Berlin JA; Kinman JL; Spitz PW; Hennessy S; Feldman H; Kimmel S; Carson JL JAMA; 1996 Feb; 275(5):376-82. PubMed ID: 8569017 [TBL] [Abstract][Full Text] [Related]
3. [Ketorolac tromethamine--with special reference to postoperative pain therapy]. Andersen SS; Jensen ME Ugeskr Laeger; 1994 Feb; 156(8):1160-3. PubMed ID: 8116102 [No Abstract] [Full Text] [Related]
4. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. Dodenhoff RM J Bone Joint Surg Am; 1996 Jun; 78(6):968. PubMed ID: 8666615 [No Abstract] [Full Text] [Related]
5. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. Linville D J Bone Joint Surg Am; 1996 Jun; 78(6):967-8. PubMed ID: 8666614 [No Abstract] [Full Text] [Related]
6. Intranasal ketorolac (Sprix). Med Lett Drugs Ther; 2012 Jan; 54(1382):7-8. PubMed ID: 22267216 [No Abstract] [Full Text] [Related]
7. Ketorolac tromethamine - routes and clinical implications. Vadivelu N; Gowda AM; Urman RD; Jolly S; Kodumudi V; Maria M; Taylor R; Pergolizzi JV Pain Pract; 2015 Feb; 15(2):175-93. PubMed ID: 24738596 [TBL] [Abstract][Full Text] [Related]
8. Ketorolac: a new parenteral nonsteroidal anti-inflammatory drug for postoperative pain management. Lassen K; Epstein-Stiles M; Olsson GL J Post Anesth Nurs; 1992 Aug; 7(4):238-42. PubMed ID: 1494990 [TBL] [Abstract][Full Text] [Related]
9. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. Duong HV; Westfield KC; Chalkley TH J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399 [TBL] [Abstract][Full Text] [Related]
10. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Trattler W; McDonald M Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313 [TBL] [Abstract][Full Text] [Related]
11. Gastric ulcer perforation associated with the use of injectable ketorolac. Estes LL; Fuhs DW; Heaton AH; Butwinick CS Ann Pharmacother; 1993 Jan; 27(1):42-3. PubMed ID: 8431619 [TBL] [Abstract][Full Text] [Related]
12. Bleeding risk with ketorolac after lumbar microdiscectomy. Chin KR; Sundram H; Marcotte P J Spinal Disord Tech; 2007 Apr; 20(2):123-6. PubMed ID: 17414980 [TBL] [Abstract][Full Text] [Related]
13. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Lindstrom R; Holland E; Lane S; Raizman M; Reilly C Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679 [No Abstract] [Full Text] [Related]
14. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Toyos R Cornea; 2008 Apr; 27(3):384; author reply 384-5. PubMed ID: 18362678 [No Abstract] [Full Text] [Related]